The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2

作者：

Nath, Karthik ^{[1
]}

Mailankody, Sham ^{[1
,2
,3
]}

Usmani, Saad Z. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[3] Weill Cornell Med Coll, Dept Med, New York, NY USA

[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA

[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期

关键词：

CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;

D O I：

10.1016/j.hoc.2023.05.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1201 / 1214

页数：14

共 50 条

[21] A new era in myeloma: the advent of chimeric antigen receptor-T (CAR-T) cells and bispecific antibodies
Ho, P. Joy
Li, Eric W.
INTERNAL MEDICINE JOURNAL, 2025,
[22] Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
Ma, Kun
Hu, Ping
CANCERS, 2023, 15 (23)
[23] Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
Grywalska, Ewelina
Sosnowska-Pasiarska, Barbara
Smok-Kalwat, Jolanta
Pasiarski, Marcin
Niedzwiedzka-Rystwej, Paulina
Rolinski, Jacek
CELLS, 2020, 9 (04)
[24] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
Yang, Jinrong
Zhou, Weilin
Li, Dan
Niu, Ting
Wang, Wei
CANCER LETTERS, 2023, 553
[25] Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?
Zhou, Xiang
Kortuem, K. Martin
Rasche, Leo
Einsele, Hermann
PRESSE MEDICALE, 2025, 54 (01):
[26] Augmenting the landscape of chimeric antigen receptor T-cell therapy
Srivastava, Shalini
Singh, Sanjay
Singh, Ajay
EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (08) : 755 - 773
[27] Empowering chimeric antigen receptor T-cell therapy with CRISPR
Zhou, Xuanzhu
BIOTECHNIQUES, 2020, 68 (04) : 169 - 171
[28] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
Atrash, Shebli
Ali, Syed Abbas
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01) : 21 - 34
[29] Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Dhawale, Tejaswini
Johnson, P. Connor
Boateng, Kofi
Barata, Anna
Traeger, Lara
Nelson, Ashley M.
Lavoie, Mitchell W.
Holmbeck, Katherine
Choe, Joanna
Nabily, Anisa
Tripathi, Astha
Amonoo, Hermioni L.
Frigault, Matt
El-Jawahri, Areej
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 402.e1 - 402.e12
[30] Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19+ Tumors
Grover, Natalie S.
Tschernia, Nicholas
Dotti, Gianpietro
Savoldo, Barbara
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 499 - +

← 1 2 3 4 5 →